Body traffic: Ecology, genetics, and immunity in inflammatory bowel disease

被引:32
作者
Braun, Jonathan [1 ]
Wei, Bo [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
ulcerative colitis; Crohns disease; microbiology; mucosal immunology; immunoregulation; mucosal barrier; mucus; disease biomarkers;
D O I
10.1146/annurev.pathol.1.110304.100128
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The abundant bacteria and other microbial residents of the human intestine play important roles in nutrient absorption, energy metabolism, and defense against microbial pathogens. The mutually beneficial relationship of host and commensal microbiota represents an ancient and major coevolution in composition and mutual regulation of the human mucosa and the resident microbial community. Inflammatory bowel disease (IBD) is a set of chronic, relapsing inflammatory intestinal diseases in which rules of normal host-microbial interaction have been violated. This review considers the components of this host-microbial mutualism and the ways in which it is undermined by pathogenic microbial traits and by host immune and epithelial functions that confer to them susceptibility in patients with IBD. Recent advances in understanding the genetics of IBD and the immunology of host-microbial interaction are opening new strategies for treatments that target host susceptibility, candidate microbial pathogens, and intestinal ecology.
引用
收藏
页码:401 / 429
页数:29
相关论文
共 177 条
[1]   TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells [J].
Abreu, MT ;
Arnold, ET ;
Thomas, LS ;
Gonsky, R ;
Zhou, YH ;
Hu, B ;
Arditi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :20431-20437
[2]   Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease [J].
Abreu, MT ;
Taylor, KD ;
Lin, YC ;
Hang, T ;
Gaiennie, J ;
Landers, CJ ;
Vasiliauskas, EA ;
Kam, LY ;
Rojany, M ;
Papadakis, KA ;
Rotter, JI ;
Targan, SR ;
Yang, HY .
GASTROENTEROLOGY, 2002, 123 (03) :679-688
[3]  
Agace WW, 2000, EUR J IMMUNOL, V30, P819, DOI 10.1002/1521-4141(200003)30:3<819::AID-IMMU819>3.3.CO
[4]  
2-P
[5]   The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[6]   Toll-like receptors and innate immunity [J].
Akira, S .
ADVANCES IN IMMUNOLOGY, VOL 78, 2001, 78 :1-56
[7]   Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis:: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine [J].
Andres, PG ;
Beck, PL ;
Mizoguchi, E ;
Mizoguchi, A ;
Bhan, AK ;
Dawson, T ;
Kuziel, WA ;
Maeda, N ;
MacDermott, RP ;
Podolsky, DK ;
Reinecker, HC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6303-6312
[8]   Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype [J].
Arnott, IDR ;
Landers, CJ ;
Nimmo, EJ ;
Drummond, HE ;
Smith, BKR ;
Targan, SR ;
Satsangi, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2376-2384
[9]   High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease [J].
Autschbach, F ;
Eisold, S ;
Hinz, U ;
Zinser, S ;
Linnebacher, M ;
Giese, T ;
Löffler, T ;
Büchler, MW ;
Schmidt, J .
GUT, 2005, 54 (07) :944-949
[10]   Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease [J].
Bamias, G ;
Martin, C ;
Marini, M ;
Hoang, S ;
Mishina, M ;
Ross, WG ;
Sachedina, MA ;
Friel, CM ;
Mize, J ;
Bickston, SJ ;
Pizarro, TT ;
Wei, P ;
Cominelli, F .
JOURNAL OF IMMUNOLOGY, 2003, 171 (09) :4868-4874